Szlam F - Search Results

1

Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.

Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA. Guzzetta NA, et al. Among authors: szlam ad, szlam f. Br J Anaesth. 2014 Feb;112(2):319-27. doi: 10.1093/bja/aet355. Epub 2013 Nov 4. Br J Anaesth. 2014. PMID: 24193321 Free article.

2

Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.

Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Mochizuki T, et al. Among authors: szlam f. Anesth Analg. 1998 Oct;87(4):781-5. doi: 10.1097/00000539-199810000-00008. Anesth Analg. 1998. PMID: 9768770

3

The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery.

Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, Levy JH. Tsuda A, et al. Among authors: szlam f. Anesth Analg. 2001 Dec;93(6):1453-9, table of contents. doi: 10.1097/00000539-200112000-00020. Anesth Analg. 2001. PMID: 11726422

4

Weal and flare responses to intradermal rocuronium and cisatracurium in humans.

Levy JH, Gottge M, Szlam F, Zaffer R, McCall C. Levy JH, et al. Among authors: szlam f. Br J Anaesth. 2000 Dec;85(6):844-9. doi: 10.1093/bja/85.6.844. Br J Anaesth. 2000. PMID: 11732517 Free article.

5

The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.

Sato N, Tanaka KA, Szlam F, Tsuda A, Arias ME, Levy JH. Sato N, et al. Among authors: szlam f. Anesth Analg. 2003 Feb;96(2):539-44, table of contents. doi: 10.1097/00000539-200302000-00044. Anesth Analg. 2003. PMID: 12538209

6

In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery.

Tanaka KA, Szlam F, Katori N, Tsuda A, Levy JH. Tanaka KA, et al. Among authors: szlam f. Br J Anaesth. 2004 Aug;93(2):257-62. doi: 10.1093/bja/aeh189. Epub 2004 May 28. Br J Anaesth. 2004. PMID: 15169740 Free article.

7

Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.

Tanaka KA, Szlam F, Katori N, Vega JD, Levy JH. Tanaka KA, et al. Among authors: szlam f. Thromb Res. 2004;113(5):333-9. doi: 10.1016/j.thromres.2004.03.022. Thromb Res. 2004. PMID: 15183046

8

Effects of tirofiban on haemostatic activation in vitro.

Tanaka KA, Katori N, Szlam F, Sato N, Kelly AB, Levy JH. Tanaka KA, et al. Among authors: szlam f. Br J Anaesth. 2004 Aug;93(2):263-9. doi: 10.1093/bja/aeh193. Epub 2004 Jun 11. Br J Anaesth. 2004. PMID: 15194626 Free article.

9

Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.

Tanaka KA, Szlam F, Kelly AB, Vega JD, Levy JH. Tanaka KA, et al. Among authors: szlam f. Platelets. 2004 Aug;15(5):325-32. doi: 10.1080/09537100410001710236. Platelets. 2004. PMID: 15370104 Free article.

10

The effects of argatroban on thrombin generation and hemostatic activation in vitro.

Tanaka KA, Szlam F, Katori N, Sato N, Vega JD, Levy JH. Tanaka KA, et al. Among authors: szlam f. Anesth Analg. 2004 Nov;99(5):1283-1289. doi: 10.1213/01.ANE.0000134685.75813.EB. Anesth Analg. 2004. PMID: 15502018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters